
Christopher W. Fulton
Examiner (ID: 16699, Phone: (571)272-2242 , Office: P/2855 )
| Most Active Art Unit | 2855 |
| Art Unit(s) | 2859, 3641, 2406, 2899, 2841, 2855, 3108, 2856 |
| Total Applications | 3373 |
| Issued Applications | 2875 |
| Pending Applications | 85 |
| Abandoned Applications | 419 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4827314
[patent_doc_number] => 20080125581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'Methods and compositions for controlled polypeptide synthesis'
[patent_app_type] => utility
[patent_app_number] => 12/006440
[patent_app_country] => US
[patent_app_date] => 2008-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 36747
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20080125581.pdf
[firstpage_image] =>[orig_patent_app_number] => 12006440
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/006440 | Methods and compositions for controlled polypeptide synthesis | Jan 1, 2008 | Issued |
Array
(
[id] => 4955390
[patent_doc_number] => 20080188414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-07
[patent_title] => 'Factor IX moiety-polymer conjugates having a releasable linkage'
[patent_app_type] => utility
[patent_app_number] => 12/006073
[patent_app_country] => US
[patent_app_date] => 2007-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12881
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20080188414.pdf
[firstpage_image] =>[orig_patent_app_number] => 12006073
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/006073 | Factor IX moiety-polymer conjugates having a releasable linkage | Dec 26, 2007 | Issued |
Array
(
[id] => 7703196
[patent_doc_number] => 08088951
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-03
[patent_title] => 'Epigenetic mechanisms re-establish access to long-term memory after neuronal loss'
[patent_app_type] => utility
[patent_app_number] => 11/998834
[patent_app_country] => US
[patent_app_date] => 2007-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 85
[patent_no_of_words] => 19982
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/088/08088951.pdf
[firstpage_image] =>[orig_patent_app_number] => 11998834
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/998834 | Epigenetic mechanisms re-establish access to long-term memory after neuronal loss | Nov 29, 2007 | Issued |
Array
(
[id] => 5581354
[patent_doc_number] => 20090176700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'Derivatives Of GLP-1 Analogs'
[patent_app_type] => utility
[patent_app_number] => 11/944757
[patent_app_country] => US
[patent_app_date] => 2007-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 170418
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20090176700.pdf
[firstpage_image] =>[orig_patent_app_number] => 11944757
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/944757 | Derivatives of GLP-1 analogs | Nov 25, 2007 | Issued |
Array
(
[id] => 6602848
[patent_doc_number] => 20100062980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'THERAPEUTIC USES OF BETA-ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/516550
[patent_app_country] => US
[patent_app_date] => 2007-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 17258
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20100062980.pdf
[firstpage_image] =>[orig_patent_app_number] => 12516550
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/516550 | THERAPEUTIC USES OF BETA-ANTAGONISTS | Nov 25, 2007 | Abandoned |
Array
(
[id] => 5337278
[patent_doc_number] => 20090053742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'Capture and release based isotope tagged peptides and methods for using the same'
[patent_app_type] => utility
[patent_app_number] => 11/985768
[patent_app_country] => US
[patent_app_date] => 2007-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15095
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20090053742.pdf
[firstpage_image] =>[orig_patent_app_number] => 11985768
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/985768 | Capture and release based isotope tagged peptides and methods for using the same | Nov 15, 2007 | Abandoned |
Array
(
[id] => 4704103
[patent_doc_number] => 20080063626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'MINIMIZATION OF DRUG OXIDATION IN DRUG IRRADIATED EXCIPIENTS FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 11/940085
[patent_app_country] => US
[patent_app_date] => 2007-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3061
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20080063626.pdf
[firstpage_image] =>[orig_patent_app_number] => 11940085
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/940085 | MINIMIZATION OF DRUG OXIDATION IN DRUG IRRADIATED EXCIPIENTS FORMULATIONS | Nov 13, 2007 | Abandoned |
Array
(
[id] => 4764587
[patent_doc_number] => 20080175798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'PEPTIDE-BASED HAIR PROTECTANTS'
[patent_app_type] => utility
[patent_app_number] => 11/939583
[patent_app_country] => US
[patent_app_date] => 2007-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12142
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20080175798.pdf
[firstpage_image] =>[orig_patent_app_number] => 11939583
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/939583 | PEPTIDE-BASED HAIR PROTECTANTS | Nov 13, 2007 | Abandoned |
Array
(
[id] => 4778231
[patent_doc_number] => 20080286229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'METHOD TO PROMOTE HAIR GROWTH AND/OR DELAY OR TREAT HAIR LOSS BY ADMINISTERING A TGF-BETA ANTAGONIST OR INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 11/939126
[patent_app_country] => US
[patent_app_date] => 2007-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6961
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20080286229.pdf
[firstpage_image] =>[orig_patent_app_number] => 11939126
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/939126 | Method to promote hair growth and/or delay or treat hair loss by administering a TGF-β antagonist or inhibitor | Nov 12, 2007 | Issued |
Array
(
[id] => 8653200
[patent_doc_number] => 08372950
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-12
[patent_title] => 'IgG binding peptide'
[patent_app_type] => utility
[patent_app_number] => 12/312268
[patent_app_country] => US
[patent_app_date] => 2007-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 21037
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12312268
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/312268 | IgG binding peptide | Nov 1, 2007 | Issued |
Array
(
[id] => 4823643
[patent_doc_number] => 20080227954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis'
[patent_app_type] => utility
[patent_app_number] => 11/981669
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30986
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227954.pdf
[firstpage_image] =>[orig_patent_app_number] => 11981669
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/981669 | Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis | Oct 30, 2007 | Abandoned |
Array
(
[id] => 4740814
[patent_doc_number] => 20080234467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis'
[patent_app_type] => utility
[patent_app_number] => 11/981814
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30980
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20080234467.pdf
[firstpage_image] =>[orig_patent_app_number] => 11981814
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/981814 | Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis | Oct 30, 2007 | Abandoned |
Array
(
[id] => 4786456
[patent_doc_number] => 20080139785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis'
[patent_app_type] => utility
[patent_app_number] => 11/981811
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30981
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0139/20080139785.pdf
[firstpage_image] =>[orig_patent_app_number] => 11981811
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/981811 | Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis | Oct 30, 2007 | Abandoned |
Array
(
[id] => 4720314
[patent_doc_number] => 20080242837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'Peptide compositions'
[patent_app_type] => utility
[patent_app_number] => 11/986043
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 22644
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20080242837.pdf
[firstpage_image] =>[orig_patent_app_number] => 11986043
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/986043 | Peptide compositions | Oct 29, 2007 | Abandoned |
Array
(
[id] => 5527725
[patent_doc_number] => 20090197802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'Analogues of GLP-1'
[patent_app_type] => utility
[patent_app_number] => 11/929013
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21245
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20090197802.pdf
[firstpage_image] =>[orig_patent_app_number] => 11929013
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/929013 | Analogues of GLP-1 | Oct 29, 2007 | Issued |
Array
(
[id] => 6574847
[patent_doc_number] => 20100273702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'CHIMERICAL PEPTIDIC MOLECULES WITH ANTIVIRAL PROPERTIES AGAINST THE VIRUSES OF THE FLAVIVIRIDAE FAMILY'
[patent_app_type] => utility
[patent_app_number] => 12/513085
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16318
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0273/20100273702.pdf
[firstpage_image] =>[orig_patent_app_number] => 12513085
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/513085 | Chimerical peptidic molecules with antiviral properties against the viruses of the Flaviviridae family | Oct 29, 2007 | Issued |
Array
(
[id] => 4938463
[patent_doc_number] => 20080075782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'Pulmonary delivery of active fragments parathyroid hormone'
[patent_app_type] => utility
[patent_app_number] => 11/981198
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3947
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20080075782.pdf
[firstpage_image] =>[orig_patent_app_number] => 11981198
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/981198 | Pulmonary delivery of active fragments parathyroid hormone | Oct 29, 2007 | Abandoned |
Array
(
[id] => 4894193
[patent_doc_number] => 20080103292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-01
[patent_title] => 'Glycopeptide derivatives and pharmaceutical compositions containing the same'
[patent_app_type] => utility
[patent_app_number] => 11/977377
[patent_app_country] => US
[patent_app_date] => 2007-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29900
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20080103292.pdf
[firstpage_image] =>[orig_patent_app_number] => 11977377
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/977377 | Glycopeptide derivatives and pharmaceutical compositions containing the same | Oct 23, 2007 | Issued |
Array
(
[id] => 4840324
[patent_doc_number] => 20080280810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'PEPTIDES HAVING AFFINITY FOR BODY SURFACES'
[patent_app_type] => utility
[patent_app_number] => 11/877692
[patent_app_country] => US
[patent_app_date] => 2007-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 24842
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20080280810.pdf
[firstpage_image] =>[orig_patent_app_number] => 11877692
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/877692 | PEPTIDES HAVING AFFINITY FOR BODY SURFACES | Oct 23, 2007 | Abandoned |
Array
(
[id] => 6359103
[patent_doc_number] => 20100087383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-08
[patent_title] => 'INTRACEREBRAL OXIDATION INHIBITOR AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/446893
[patent_app_country] => US
[patent_app_date] => 2007-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5176
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20100087383.pdf
[firstpage_image] =>[orig_patent_app_number] => 12446893
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/446893 | INTRACEREBRAL OXIDATION INHIBITOR AND USE THEREOF | Oct 22, 2007 | Abandoned |